-

Outlook on the Worldwide Healthcare Mobility Solution Industry to 2024 - by Products and Services, Application, End Use Industry & Region - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Healthcare Mobility Solution Market Report: Trends, Forecast, and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering.

The future of the healthcare mobility solutions market looks promising with opportunities in the payers, providers (hospitals and laboratories), and patients industries. The global healthcare mobility solutions market is expected to grow with a CAGR of 28.4% from 2019 to 2024. The major drivers for this market are the rising need to reduce healthcare costs and enhance clinical efficiency; growing adoption of smartphones, tablets, and PDA in the healthcare ecosystem; availability of advanced connectivity to enhance the quality of healthcare mobility solutions; and better cost efficiency encouraging medical professionals to adopt healthcare mobility solutions.

A report of more than 150 pages is developed to help in your business decisions. To learn the scope of, benefits, companies researched and other details of the healthcare mobility solutions market, then read this report.

The study includes the healthcare mobility solutions market size and forecast for the global healthcare mobility solutions market through 2024, segmented by product and services, application, end use industry, and the region as follows:

Key Questions Answered

  1. What are some of the most promising potential, high-growth opportunities for the global healthcare mobility solutions market by products and services (mobile devices (mobile computers, RFID scanners, barcode scanners, and others.), mobile applications (apps), and enterprise mobility platforms), application (enterprise solutions (patient care management, operations management and workforce management) and mhealth applications (chronic care management, exercise, weight loss, women's health, sleep monitoring, medication management, and others.), end use industry (payers, providers (hospitals, laboratories, and others.), and patients), and region (North America, Europe, Asia-Pacific, and Rest of the World (RoW))
  2. Which segments will grow at a faster pace and why?
  3. Which regions will grow at a faster pace and why?
  4. What are the key factors affecting market dynamics? What are the drivers and challenges of the healthcare mobility solutions market?
  5. What are the business risks and threats to the healthcare mobility solutions market?
  6. What are emerging trends in this healthcare mobility solutions market and the reasons behind them?
  7. What are some changing demands of customers in the healthcare mobility solutions market?
  8. What are the new developments in the healthcare mobility solutions market? Which companies are leading these developments?
  9. Who are the major players in this healthcare mobility solutions market? What strategic initiatives are being implemented by key players for business growth?
  10. What are some of the competitive products and processes in this healthcare mobility solutions area and how big of a threat do they pose for loss of market share via material or product substitution?
  11. What M & A activities have taken place in the last 5 years in this, healthcare mobility solutions market?

Key Topics Covered:

1. Executive Summary

2. Market Background and Classifications

3. Market Trends and Forecast Analysis from 2013 to 2024

3.1: Macroeconomic Trends and Forecast

3.2: Global Healthcare Mobility Solution Market: Trends and Forecast

3.3: Global Healthcare Mobility Solution Market by Products and Services

3.3.1: Mobile Devices

3.3.2: Mobile Applications (Apps)

3.4: Global Healthcare Mobility Solution Market by Application

3.4.1: Enterprise Solutions

3.4.2: mHealth Applications (Patient-centric Applications)

3.5: Global Healthcare Mobility Solution Market by End Use Industry

3.5.1: Payers

3.5.2: Providers

3.5.3: Patients

4. Market Trends and Forecast Analysis by Region

4.1: Global Healthcare Mobility Solution Market by Region

4.2: North American Healthcare Mobility Solutions Market

4.2.1: Market by Products and Services: Mobile Devices and Mobile Applications (Apps)

4.2.2: Market by Application: Enterprise Solutions and mHealth Applications (Patient-centric Applications)

4.2.3: Market by End Use Industry: Payers, Providers, and Patients

4.3: European Healthcare Mobility Solution Market

4.4: APAC Healthcare Mobility Solution Market

4.5: ROW Healthcare Mobility Solution Market

5. Competitor Analysis

5.1: Product Portfolio Analysis

5.2: Market Share Analysis

5.3: Operational Integration

5.4: Geographical Reach

5.5: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis

6.1.1: Growth Opportunities for Global Healthcare Mobility Solution Market by Products and Services

6.1.2: Growth Opportunities for Global Healthcare Mobility Solution Market by Application

6.1.3: Growth Opportunities for Global Healthcare Mobility Solution Market by End Use Industry

6.1.4: Growth Opportunities for Global Healthcare Mobility Solution Market by Region

6.2: Emerging Trends in Global Healthcare Mobility Solution Market

6.3: Strategic Analysis

6.3.1: New Product Development

6.3.2: Capacity Expansion of Global Healthcare Mobility Solution Market

6.3.3: Mergers, Acquisitions and Joint Ventures in the Global Market

7. Company Profiles of Leading Players

7.1: Oracle Corporation

7.2: At&T

7.3: Cisco Systems

7.4: Philips Healthcare

7.5: Sap Se

7.6: Zebra Technologies Corporation

7.7: Cerner Corporation

7.8: Mckesson Corporation

7.9: Omron Corporation

7.10: Airstrip Technologies

For more information about this report visit https://www.researchandmarkets.com/r/fic9sr

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Blockchain and Non-Fungible Tokens new Technologies and the Relevant Law Training Course: Core Principles, Smart Contracts, NFTs, and Decentralized Finance Explained (Online Event: May 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blockchain and Non-Fungible Tokens: Understanding new Technologies and the Relevant Law Training Course (May 20, 2026)" training has been added to ResearchAndMarkets.com's offering. Blockchain is a new technology that could potentially have major impacts in a wide range of industries. It has the potential to dramatically change how business is conducted - but there is no one central authority controlling blockchain, everyone has access to the same information. Are...

Writing Clinical Research with Integrity Training Course: Principles of Medical and Scientific Writing, Including Ethical Standards, Data Integrity, and Plagiarism Prevention (Online: Apr 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers key principles of medical and scientific writing, including ethical standards, data integrity, and plagiarism prevention. Participants will learn how to tailor content for various audiences, structure documents (e.g., manuscripts, protocols), and adhere to writing standards such as clarity, consistency, and correc...

In-Vitro Diagnostic Regulation (EU) 2017/746 Introduction Training Course (Online Event: Apr 16th - Apr 17th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (Apr 16th - Apr 17th, 2026)" training has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition period of five years, is intended to strengthen the current approval system for in-vitro diagnostics and makes substantial changes to the existing IVD Directive (98/79/EC) legislation. The Regulation in...
Back to Newsroom